Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Transplantation Proceedings|December 23, 2008
Prolonged survival of renal allograft in rats by methotrexate-albumin conjugates as immunosuppressive therapyH Hickstein, D Wolff, J Stange, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|February 5, 1999
[Adjuvant radiochemotherapy with 5-FU and folinic acid in Dukes stage B and C rectum carcinoma: an interim analysis]E Hagmüller, G Hartung, J Sturm, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in miceM Zeis, L Uharek, G Hartung, et al.
Bone Marrow Transplantation|March 30, 2001
Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in miceM Zeis, J Steinmann, E Petrela, et al.
International Journal of Cancer|May 8, 2001
Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivoA M Burger, G Hartung, G Stehle, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 18, 2004
A general study of [(eta5-Cp')2Ti(eta2-Me3SiC2SiMe3)]-catalyzed hydroamination of terminal alkynes: regioselective formation of Markovnikov and anti-Markovnikov products and mechanistic explanation (Cp'=C5H5, C5H4Et, C5Me5)Annegret Tillack, Haijun Jiao, Ivette Garcia Castro, et al.
Annals of Hematology|November 28, 2002
Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantationC Kahl, M Leithäuser, D Wolff, et al.
Anti-Cancer Drugs|June 23, 1999
Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing ratsG Stehle, A Wunder, H H Schrenk, et al.
Bone Marrow Transplantation|June 20, 2003
Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation modelG Hartung, M Zeis, B Glass, et al.
Anti-Cancer Drugs|November 26, 1999
Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugateG Stehle, A Wunder, H H Schrenk, et al.
Pageof 5